Organization
Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS
5 abstracts
2 posters
Abstract
Depicting oncologists' perceptions and knowledge of global disparities in conflicts of interest reporting: The ONCOTRUST-1 study.Org: Faculty of Medical Sciences, University Mohammed VI Polytechnic, National Institute of Oncology. Istenhegyi Géndiagnosztika Private Health Center Oncology Clinic, Evercare Hospital Dhaka, Kenyatta University Teaching,
Abstract
Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response.Org: Memorial Sloan Kettering Cancer Center, Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, European Institute of Oncology IRCCS, Breast Service, Department of Surgery, Oncology and Gastroenterology, University of Padova, Oncology 2, IOV - Istituto Oncologico Veneto IRCCS -IOV,
Abstract
CCNE1 amplification as marker of poor prognosis and novel therapeutic target in advanced breast cancer.Org: Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Repare Therapeutics, Saint-Laurent, QC, Canada, Repare Therapeutics, Cambridge, MA, University of Milan and European Institute of Oncology, IRCCS, Milan, Italy,
Abstract
Unfavourable carcinoma of unknown primary (CUP) with gastrointestinal profile: A retrospective study.Org: Istituto Europeo di Oncologia IRCCS, Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, European Institute of Oncology IRCCS, University of Milano, European Institute of Oncology, Division of Early Drug Development, European Institute of Oncology (IEO),
Abstract
Cardiovascular events in patients receiving immuno-oncology agents, in phase I clinical trials: CAVIO study.Org: Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, European Institute of Oncology IRCCS, University of Milano, European Institute of Oncology, Division of Early Drug Development, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, IEO - Istituto Europeo di Oncologia IRCCS, Milan, Italy,